IP Library Granted Patent US 11,672,600
Granted Patent B2
US 11,672,600 · App. 16/864,358 · Granted Jun 13, 2023

Bodily substance detection by evaluating photoluminescent response to excitation radiation

Inventors: Ralf Brinkmann (Grevenbroich, DE); Birgit Lange (Lübeck, DE)
Assignee: Boston Scientific Corporation
A61B18/26A61B5/0071A61B5/0075A61B5/0084A61B5/06A61B18/20A61B18/24A61B18/245A61B5/20A61B2017/00061A61B2017/00066A61B2018/00505A61B2018/00577A61B2018/00666A61B2018/00773A61B2018/00785A61B2018/00904
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,672,600
App. No.
16/864,358
Granted
Jun 13, 2023
Kind
B2
Abstract

A medical device may include an ablation device configured to deliver ablation energy to a treatment site. The medical device may further include a probe device configured to deliver excitation radiation to the treatment site. Further the medical device may include a radiation-receiving device configured to receive photoluminescence radiation emitted from the treatment site in response to the treatment site being illuminated by the excitation radiation and to generate a detection signal in response to the received photoluminescence radiation. Additionally, the excitation radiation may be different from the ablation energy.

Claims (35)

1. A controller for a laser system, the controller configured to:

control a laser source configured to generate an excitation radiation in a pulsed manner having a wavelength in the visible spectrum of light to a treatment site;

discriminate a target from a remainder of the treatment site based on radiation received from the treatment site;

control the laser source configured to generate an ablation energy to damage the target; and

control the laser source to continue to generate the excitation radiation while the laser source generates the ablation energy.

2. The controller of claim 1 , wherein the ablation energy has a wavelength of about 1600 nm to about 2500 nm.

3. The controller of claim 1 , wherein the controller is configured to control the laser source to generate the excitation radiation in the pulsed manner such that a duration of each pulse of the excitation radiation is between 100 picoseconds and 100 milliseconds.

4. The controller of claim 1 , wherein the wavelength of the excitation radiation is about 532 nm.

5. The controller of claim 1 , wherein the controller is further configured to control the laser source to deliver the ablation energy with a wavelength in the invisible spectrum of light.

6. The controller of claim 1 , wherein the controller is further configured to compare an intensity of the received radiation to a threshold intensity to discriminate the target from a remainder of the treatment site.

7. The controller of claim 6 , wherein the controller is further configured to stop damaging the target via the ablation energy based on the intensity of the received radiation.

8. The controller of claim 6 , wherein the controller is further configured to stop damaging the target via the ablation energy when the intensity of the received radiation is above the threshold intensity.

9. The controller of claim 1 , wherein the controller is further configured to control the laser system to damage the target via the ablation energy in response to the received radiation from the treatment site.

10. The controller of claim 1 , wherein the laser source includes a pump laser generating the excitation radiation at a different wavelength than a wavelength of the ablation energy.

11. The controller of claim 1 , wherein the controller is further configured to control the laser source to deliver the excitation radiation to a first volume of tissue and deliver the ablation energy to a second volume of tissue, wherein the first volume of tissue is different than the second volume of tissue.

12. A controller for a laser system, the controller configured to:

control a laser source to select an energy of an excitation radiation based on a tissue type of a target to be discriminated;

generate the excitation radiation in a pulsed manner to a treatment site;

discriminate the target from a remainder of the treatment site based on radiation received from the treatment site being greater than a threshold;

control a Ho:Yag laser source to generate an ablation energy; and

control the laser system to continue to deliver the excitation radiation while the ablation energy is generated.

13. The controller of claim 12 , wherein the controller is configured to integrate all wavelengths contained in the radiation received from the target into a single intensity value.

14. The controller of claim 12 , wherein the controller is further configured to:

control the Ho:Yag laser source to generate the ablation energy in a pulsed manner; and

control the laser source to deliver radiation having a wavelength in the invisible spectrum of light.

15. The controller of claim 12 , wherein the controller is further configured to control the Ho:Yag laser source to stop damaging the target via the ablation energy based on an intensity of the received radiation.

16. A controller for a laser system, the controller configured to:

control a Ho:Yag laser source configured to generate an excitation radiation in a pulsed manner having a wavelength in the visible spectrum of light to a treatment site;

discriminate a target from a remainder of the treatment site based on radiation received from the treatment site;

control the Ho:Yag laser source to generate an ablation energy to damage the target; and

continue to control the Ho:Yag laser source to generate the excitation radiation while the laser source generates the ablation energy.

17. The controller of claim 16 , wherein the controller is further configured to control the Ho:Yag laser source to pulse the excitation radiation at a rate between 100 picoseconds and 100 milliseconds.

18. The controller of claim 16 , wherein the wavelength of the excitation radiation is about 532 nm.

19. The controller of claim 16 , wherein the controller is further configured to control the Ho:Yag laser source to stop generating the ablation energy when an intensity of the received radiation is below a predetermined threshold intensity.

20. The controller of claim 16 , wherein the controller is further configured to control the Ho:Yag laser system to generate the ablation energy in response to the radiation received from the treatment site.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2020
From: BRINKMANN, RALF
To: UNIVERSITY OF LUBECK
Reel/Frame 053105/0556 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2020
From: LANGE, BIRGIT
To: MEDIZINISCHES LASERZENTRUM LUBECK
Reel/Frame 053105/0574 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2020
From: UNIVERSITY OF LUBECK
To: MEDIZINISCHES LASERZENTRUM LUBECK
Reel/Frame 053105/0584 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2020
From: MEDIZINISCHES LASERZENTRUM LUBECK
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 053117/0772 →
Continuity (3)
Continuation 15177888 · Jun 9, 2016
Provisional Application 62173840 · Jun 10, 2015
Related Publication 20200253665A1 · Aug 13, 2020